Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08KYN
|
|||
Former ID |
DIB010993
|
|||
Drug Name |
INNO-105
|
|||
Synonyms |
Opioid growth factor (cancer), Innovive/Penn State; (MEt5)-enkephalin (cancer), Innovive/Penn State
Click to Show/Hide
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
Company |
Pennsylvania State University
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Opioid receptor zeta (OGFR) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00255333) INNO-105 in Patients With Solid Tumors. U.S. National Institutes of Health. | |||
REF 2 | National Cancer Institute Drug Dictionary (drug id 428488). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.